Načítá se...
Brain Targeting of Acyl-CoA:Cholesterol O-Acyltransferase-1 Inhibitor K-604 via the Intranasal Route Using a Hydroxycarboxylic Acid Solution
[Image: see text] An acyl-CoA:cholesterol O-acyltransferase-1 (ACAT-1/SOAT-1) inhibitor, K-604 is a promising drug candidate for the treatment of Alzheimer’s disease and glioblastoma; however, it exhibits poor solubility in neutral water and low permeability across the blood–brain barrier. In this s...
Uloženo v:
| Vydáno v: | ACS Omega |
|---|---|
| Hlavní autoři: | , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
American Chemical Society
2019
|
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6796924/ https://ncbi.nlm.nih.gov/pubmed/31646241 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1021/acsomega.9b02307 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|